MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of WNT signaling

Cancer Research

Volumn 69, Issue 8, 2009, Pages 3278-3282

  Iliopoulos, Dimitrios ^a   Bimpaki, Eirini I ^b   Nesterova, Maria ^b   Stratakis, Constantine A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; HYDROCORTISONE; MICRORNA; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 INDUCIBLE SIGNALING PATHWAY PROTEIN 2; WNT1 PROTEIN;

ADRENAL CORTEX; ADRENAL HYPERPLASIA; ALGORITHM; ARTICLE; BIOINFORMATICS; CARCINOGENESIS; CELL LINE; CORRELATION ANALYSIS; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PATHOGENESIS; PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

ADRENAL CORTEX DISEASES; ALGORITHMS; COMPUTATIONAL BIOLOGY; CUSHING SYNDROME; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION PROFILING; HUMANS; HYDROCORTISONE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICRORNAS; PIGMENTATION DISORDERS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; WNT1 PROTEIN;

EID: 65949092330     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0155     Document Type: Article

References (19)

1. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 1985;64:270-83. (Pubitemid 16247109)
2. Stratakis CA. Cushing syndrome caused by adrenocortical tumors and hyperplasias corticotropin-independent Cushing syndrome. Endocr Dev 2008;13:117-32.
3. Kirsehner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92.
4. Boikos SA, Stratakis CA. Carney complex; pathology and molecular genetics. Neuroendocrinology 2006:83:189-99. (Pubitemid 44578871)
5. Horvath A, Mathyakina L, Vong Q, et al. Serial analysis of gene expression in adrenocortical hyperplasia caused hy a gennline PRKARIA mutation. J. Clin. Endocrinol. Metab. 2006;91:584-96. (Pubitemid 43236930)
6. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-31. (Pubitemid 38868508)
7. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8. (Pubitemid 40839735)
8. S. Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart: a clue to fet al. gene reprogramming in heart failure. Circulation 2007:116:258-67. (Pubitemid 47196561)
9. Nesterova M, Bossis I, Wen F, Horvath A, Matyakhina L, Stratakis CA An immortalized human cell line bearing a PRKARIA-inactivating mutation: effects of overexpression of the wild-type Allele and other protein kinase A subunits. J. Clin. Endocrinol. Metab. 2008;93: 565-71.
10. Huang JC, Babak T, Corson TW, et al. Using expression profiling data to identify human microRNA targets. Nat Methods 2007;4:1045-9. (Pubitemid 350201777)
11. Johnson CD, Esquela-Kerscher A, Stefani G, et al. The let-7 mieroRNA represses cell proliferation pathways in human cells. Cancer Res 2007:67:7713-22. (Pubitemid 47281364)
12. Gregory PA, Bert. AG, Paterson EL, et al. The miR-200 family and rniR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Mat Cell Biol. 2008:10:593-601.
13. Kulshreshtha R, Ferracin M, Wojcik SE, et al. A microRNA signature of hypoxia. Mol Cell Biol 2007;27: 1859-67. (Pubitemid 46310048)
14. Stratakis CA. Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin-independent Cushing syndrome). Endocr Dev 2008;13:117-32.
15. Stratakis CA. New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors. Mol. Cell Endocrinol. 2009;300: 152-7.
16. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Invest 2002;109:987-91.
17. Kaylor EW, Gardner EJ. Adrenal adenomas in a patient with Gardner's syndrome. Clin. Genet 1981;20: 67-73. (Pubitemid 11013012)
18. Bertherat J, Groussin E, Bertagna X, Mechanisms of disease: adrenocortical tumors-molecular advances and clinical perspectives. Nat Clin. Pract Endocrinol. Metab. 2006:2:632-41.
19. Bourdeau I, Antonini SR, Lacroix A, et al. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Oncogene 2004;23:1575-85. (Pubitemid 38406520)